GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma

Clinical trial NCT07768943 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07768943
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Natural Killer/T-cell Lymphoma

Start date: 2026-09-01
Primary completion: 2033-06-30
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.